Oct. 15, 2024 — The American Medical Association recently released  a statement urging Congress to address Medicare reform during the lame duck session later this year.

Oct. 10, 2024 — NYU Langone Health recently launched a digital pathology program, transforming disease diagnosis from microscopes to high-definition images, shareable in real time across the hospital network. This change offers unprecedented clarity for viewing human tissue samples, shorter diagnosis time and enhanced collaboration within a field that has historically been a vital but unseen engine of patient care.

Oct. 14, 2024 — Hoag, a nonprofit, regional health care delivery system in Orange County, Calif., is now offering a new technology using ultrasound energy to precisely destroy liver tumors in a single outpatient visit.

Oct. 14, 2024 — On Oct. 14, GE HealthCare launched Versana Premier, the latest release within the Versana ultrasound family of reliable, affordable, easy-to-use, and versatile ultrasound systems.

Oct. 14, 2024 – The Institute for AI Governance in Healthcare (IAIGH) has published the draft Healthcare AI Governance Standard (HAIGS) for public comment.

The comment period opened Oct. 14, 2024, and closes Nov. 14, 2024.

The draft standard is available for review and feedback at AiHealthcareGovernance.org.

HIMSS will be presenting a webinar on "Addressing the Changing Data Demands of Next-Gen Healthcare" on Nov. 13, 2024 at 1 p.m. Central time.

The delivery of next-generation patient care relies upon seamless access to comprehensive and relevant patient data. However, the proliferation of patient data silos across multiple hosted environments can present significant integration challenges. To ensure that the full potential of next-generation healthcare solutions is realized, healthcare providers must rethink their data strategy.  

A major update was made to the International Nuclear Workers Study (INWORKS), an international epidemiological study of workers in the nuclear sector to assess their risks of cancer and non-cancerous diseases.  

Oct. 3, 2024 — GE HealthCare’s MIM Software has announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to perform absorbed dose calculation of radionuclides using a Monte Carlo method. With this clearance, Monte Carlo dosimetry via the Dose Planning Method (DPM) will be available for use with MIM SurePlan MRT, MIM Software’s comprehensive solution for automating and standardizing dosimetry in Theranostics.  

October 2, 2024 – Owkin recently announce a new partnership with AstraZeneca to develop an AI-powered tool to pre-screen for gBRCA mutations (gBRCAm) in breast cancer directly from digitized pathology slides. As part of Owkin’s ongoing collaboration with Gustave Roussy and The Centre Léon Bérard through PortrAIt, a French consortium to accelerate precision medicine through AI-enabled digital pathology, this tool aims to significantly accelerate and expand access to gBRCA testing that too many patients may not be considered for.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now